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Kidney epithelial cellBK virus (BKV) is a ubiquitous human pathogen that establishes a lifelong persistent infection in kidney
epithelial cells. BKV reactivation within these cells results in a lytic infection in immunocompromised
patients. Little is known about the speciﬁc interactions of BKV and the host cell during persistence and
reactivation. We performed global cellular gene expression analyses using microarrays to characterize the
global effect of BKV on primary kidney epithelial cells during the viral life cycle. Our results demonstrate that
BKV primarily activates genes involved in cell cycle regulation and apoptosis (58% and 44% of upregulated
genes at 48 and 72 h post-infection, respectively). Surprisingly, we observed that only four genes were
downregulated during infection and that only two genes directly involved in the inﬂammatory response
were differentially expressed. These results provide information about how BKV interacts with a cell type in
which it both establishes persistence and undergoes lytic reactivation.
© 2009 Elsevier Inc. All rights reserved.Introduction
BK virus (BKV) is a member of the human polyomavirus family
that was ﬁrst isolated in 1971 from the urine of a renal transplant
recipient and is ubiquitous in the human population (Gardner et al.,
1971). Primary exposure to BKV likely results in an asymptomatic
infection during early childhood, with antibodies against BKV
detected in 50% of children by age 3 and over 90% by age 10 (Knowles,
2001).
It is widely believed that the kidney is the major reservoir for BKV:
a variety of studies have demonstrated the presence of BKV DNA and
proteins in normal and diseased human kidneys, and reactivation of
BKV leads to diseases of the kidney and urinary tract (Bedi et al., 1995;
Heritage et al., 1981; Shinohara et al., 1993). BKV lytic infection
following reactivation can be subclinical but is often associated with
hemorrhagic cystitis, an infection of the bladder characterized by
inﬂammation and hematuria in bone marrow transplant patients, or
polyomavirus nephropathy (PVN) in renal transplant patients, a
destruction of kidney tissue frequently leading to deterioration and
eventual loss of the graft (reviewed in Jiang et al., 2009a). Clinical BKV
infection has become a greater problem in recent years due to the).
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ll rights reserved.increasing prevalence of bone marrow and renal transplants, as well
as the development of more effective immunosuppressive therapies
used in these patients. The frequency of BKV viruria and viremia after
renal transplantation can be as high as 80%, with 10% of patients
progressing to PVN (Binet et al., 1999; Bressollette-Bodin et al., 2005;
Egli et al., 2007; Hirsch et al., 2002). Due to the lack of effective
antiviral drugs, the primary course of action for physicians is to
decrease immunosuppression, thereby increasing the risk of rejection.
As a result, up to 90% of patients that develop PVN lose allograft
function, and overall, BKV reactivation may be responsible for up to
10% of all renal graft dysfunction (Egli et al., 2007; Nickeleit et al.,
2000). BKV reactivation has also been detected in recipients of other
solid organ transplants, including heart, lung, liver, and pancreas
(Pavlakis et al., 2006; Vilchez and Kusne, 2006).
Transcription of the BKV genome occurs divergently from a single
non-coding control region: the early proteins, large tumor antigen
(TAg), small tumor antigen (tAg), and truncated tumor antigen
(truncTAg) are coded for by one strand, while the late proteins, VP1,
VP2, VP3, and the agnoprotein, are encoded by the opposite strand
(reviewed in Imperiale and Major, 2007). Upon transport of the viral
genome to the nucleus, the virus expresses the three T antigens. TAg
and tAg induce the non-dividing epithelial cell to enter S phase, which
facilitates replication of the genome. BKV TAg is a 695 amino acid
protein that binds to the retinoblastoma family of tumor suppressor
proteins: pRB, p107, and p130 (Harris et al., 1996). The interaction of
TAg with the pRB family members is one of the critical early events
that induce S phase progression. The binding of TAg to pRB causes
displacement of E2F transcription factor family members, which
subsequently activate transcription of genes involved in S phase
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1988; Harris et al., 1996). TAg has also been shown to prevent the cell
from undergoing cell cycle arrest or apoptosis through interactions
with the tumor suppressor protein p53 (Harris et al., 1998; Nakshatri
et al., 1988). In normal cells, p53-mediated cell cycle arrest occurs
through transcriptional activation of the genes encoding p21Waf1,
MDM2, and cyclin G1, while p53-mediated apoptosis occurs through
transcriptional activation of the Bcl-2 family, p53AIP1, and the Fas
death receptor (Vousden, 2000).
In the absence of lytic replication, the expression of BKV early
proteins can result in the oncogenic transformation of mammalian
cells in culture (Harris et al., 1996; Major and Di Mayorca, 1973) and
the development of tumors in transgenic mice (Dalrymple and
Beemon, 1990; Small et al., 1986). When BKV is injected intracere-
brally or intravenously into hamsters, rats, or newborn mice, species
in which the virus cannot lytically replicate, 75% of the animals
develop tumors containing viral sequences and proteins (Imperiale
andMajor, 2007; Uchida et al., 1976). In the presence of activated c-H-
Ras or c-Myc, BKV transforms human embryonic kidney cells,
demonstrating that under certain conditions the viral proteins may
behave similarly in human and rodent cells (Corallini et al., 1991;
Pater and Pater, 1986). Although a role for BKV in the formation of
tumors in humans remains controversial, BKV sequences have been
detected in a number of human tumors, including those of the urinary
tract (Abend et al., 2009). The transforming potential of BKV in the
absence of productive infection is directed primarily by changes in
gene expression associated with cell cycle regulation by the tumor
antigens.
Due to the increasing prevalence of BKV-associated diseases, we
are interested in global changes in cellular gene expression that occur
as a result of BKV lytic infection. In this report, we used array analyses
to characterize the effect of BKV infection on primary human proximal
tubule epithelial (HPTE) cells, which we have previously described as
a model system for BKV lytic infection (Low et al., 2004). To include
both the early and late stages of the viral life cycle in the analyses, we
chose to examine changes in cellular gene expression induced by BKV
lytic replication up to 72 h post-infection (hpi). We used quantitative
RT-PCR and immunoblotting to conﬁrm the microarray results for
several genes with signiﬁcant changes in expression in the presence of
BKV. As expected, a large number of genes involved in cell cycle
regulation and proliferation were upregulated during infection.
Surprisingly, there was no effect on the expression of pro-inﬂamma-
tory genes and only four genes were signiﬁcantly downregulated
during BKV lytic infection. These ﬁndings are important for under-
standing the host–pathogen interactions that occur between BKV and
human kidney epithelial cells, and more speciﬁcally, the cellular
environment established and required for lytic infection by BKV.
Results
Microarray analysis of BKV-infected HPTE cells
Our previous studies examined the time course of BKV infection in
HPTE cells: early viral gene expression is ﬁrst detectable at 24 hpi,
with levels increasing out to 72 hpi; synthesis of viral DNA and late
gene expression begin concurrently at 36 hpi, with levels increasing
through the late stages of infection; and viral progeny production
begins at 48 hpi (Low et al., 2004). Therefore, we chose to examine the
effects of BKV lytic infection on human kidney epithelial cells at 24, 48,
and 72 hpi to encompass both early and late stages of the infectious
cycle. HPTE cells were infected with puriﬁed BKV at an MOI of 5 IU/
cell. Total cell RNAwas extracted at 24, 48, and 72 hpi and subjected to
microarray analysis using the Affymetrix GeneChip Human Genome
U133 Plus 2.0 Array, which measures the expression level of more
than 47,000 transcripts and variants. Principal component analysis of
the data from these three time points suggested signiﬁcant differencesbetween mock- and BKV-infected samples at 48 and 72 hpi, but few
changes at 24 hpi. A two-fold cutoff was used to deﬁne genes as
signiﬁcantly affected in the presence of BKV. According to this
deﬁnition, zero genes were signiﬁcantly affected by BKV in the ﬁrst
microarray analysis at 24 hpi. A repeat analysis at 24 hpi produced a
similar result: the expression of only 16 genes, mainly involved in cell
cycle progression, was upregulated by slightly more than two-fold at
24 hpi (data not shown). However, a large number of genes were
affected by BKV infection at both the 48- and 72-h time points (Table 1,
Supplemental Tables 1, 2).
The largest category of genes upregulated in the presence of BKV
contained genes involved in regulation of cell cycle, proliferation, and
apoptosis. During BKV lytic infection, 114 out of 195 genes
signiﬁcantly upregulated at 48 h and 165 out of 372 genes
signiﬁcantly upregulated at 72 h belonged to this category (Supple-
mental Tables 1, 2). Among the genes involved in regulation of cell
cycle and proliferation were multiple members of the cell division
cycle (CDC), cyclin, and minichromosome maintenance deﬁcient
(MCM) families. Genes with altered expression also included those
involved in signal transduction, regulation of transcription and
chromatin remodeling, DNA damage repair mechanisms, protein
ubiquitination, protein folding and synthesis, RNA processing, and
cellular trafﬁcking and structure, as well as a number of genes for
which a function has not yet been deﬁned.
As would be anticipated, many of the genes induced at 48 hpi were
also signiﬁcantly, and in many cases more dramatically, upregulated
at 72 hpi (Table 1). For example, transcript levels for CDC6, an E2F
target that is required for cellular DNA replication, were elevated by 9-
fold at 48 hpi and more than 16-fold at 72 hpi. Transcript levels for
CDC2, an essential component of the M-phase promoting factor,
which regulates progression of the cell cycle, were upregulated by
more than 8-fold at 48 hpi and 13-fold at 72 hpi. Cyclin E2 (CCNE2), an
activator of cyclin-dependent kinase 2 that is also upregulated by
human papillomavirus E6 and E7 oncoproteins (Hunter and Pines,
1994; Zariwala et al., 1998), was upregulated by over 14-fold at 48 hpi
and 24-fold at 72 hpi. Table 1 presents a summary of the expression
levels of select genes that were signiﬁcantly affected by BKV infection
and are later discussed.
Very few genes were downregulated in the presence of BKV at 48
or 72 hpi. The only gene signiﬁcantly downregulated at both time
points was that encoding a disintegrin-like and metalloprotease with
thrombospondin type 1 motif, 5 (ADAMTS5), for which the major
known function is cleavage of aggrecan, a component of cartilage
(Malfait et al., 2002). In addition, the transcript levels of type I and
type III collagen genes (COL1A2, COL3A1) and a gene of unknown
function, C9orf71, were signiﬁcantly decreased at 72 hpi.
We were intrigued by the apparent lack of virus-mediated
regulation of genes involved in the immune response. To explore
this observation further, we performed PCR array analysis targeted to
common human cytokines at a very early stage of BKV infection to
determine if there is any change in cellular gene expression as a result
of viral binding and entry. HPTE cells were incubated with puriﬁed
BKV at 4 °C for 1 h to allow for binding of virions and synchronization
of viral entry. Cells were then incubated at 37 °C to initiate BKV
infection and total cell RNA was harvested at 4 hpi, when the virus is
still trafﬁcking through the cytoplasm (Jiang et al., 2009b) and would
be likely to engage innate immune receptors. Changes in expression of
various cytokines in response to the binding, entry, and trafﬁcking of
BKV were analyzed using the Common Human Cytokines quantitative
RT-PCR array (SABiosciences). In agreement with the results from the
microarray analyses at 24, 48, and 72 hpi, there were no signiﬁcant
changes in the transcript levels at 4 hpi of the 85 cytokine genes
analyzed on the array (Supplemental Table 3). We also performed
ribonuclease protection assays (RPAs) on RNA isolated from mock-
and BKV-infected HPTE cells throughout the course of infection (from
12 to 96 hpi). Using probe sets that detect almost 50 chemokines and
Table 1
Genes in HPTE cells affected 48 and 72 h post-BKV infection.
Gene
symbol
Change
(n-fold) 48 h
Change
(n-fold) 72 h
Full gene name
Cell cycle/proliferation
CCNE2 14.1 24.3 Cyclin E2
MCM10 9.1 13.6 Minichromosome
maintenance deﬁcient 10
CDC6 9.0 16.2 Cell division cycle 6
ANLN 8.3 15.8 Anillin, actin binding protein
CDC2 8.3 13.6 Cell division cycle 2
E2F8 7.1 16.5 E2F transcription factor 8
CCNA2 7.1 11.4 Cyclin A2
E2F7 5.3 10.6 E2F transcription factor 7
BUB1B 5.0 9.0 Budding uninhibited by
benzimidazoles 1 beta
BUB1 4.6 5.0 Budding uninhibited by
benzimidazoles 1
MKI67 4.2 7.9 Antigen identiﬁed by
monoclonal antibody Ki-67
PCNA 3.3 4.7 Proliferating cell nuclear antigen
Apoptosis
BIRC5 4.7 8.9 Baculoviral IAP
repeat-containing 5 (survivin)
GTSE1 3.5 7.8 G-2 and S-phase expressed 1
BCL2L12 2.1 3.6 BCL2-like 12 (proline-rich)
Signal transduction
SHCBP1 8.3 17.3 SHC SH2-domain binding protein 1
PBK 6.6 13.4 PDZ binding kinase
Chromatin remodeling
HCAP-G 7.7 13.3 Chromosome condensation protein G
BRRN1 5.0 9.6 Barren homolog, HCAP-H
HELLS 4.9 8.1 Helicase, lymphoid-speciﬁc
TCF19 4.1 9.0 Transcription factor 19 (SC1)
HMGB2 3.9 4.7 High-mobility group box 2
DNMT1 NC 2.8 DNA (cytosine-5-)-methyltransferase 1
DNA damage repair
RAD51AP1 7.8 23.4 RAD 51 associated protein 1
BRIP1 6.1 10.5 BRCA1 interacting protein
C-terminal helicase 1
BARD1 5.9 8.8 BRCA1 associated RING domain 1
RAD51 4.4 5.5 RAD51 homolog (RecA homolog)
BRCA1 2.7 4.8 Breast cancer 1, early onset
Protein ubiquitination
UBE2C 6.5 8.0 Ubiquitin-conjugating enzyme E2C
FBXO5 5.9 9.9 F-box protein 5, earlymitotic inhibitor 1
USP1 4.3 3.8 Ubiquitin speciﬁc peptidase 1
RNA processing
APOBEC3B 3.1 6.9 Apolipoprotein B mRNA editing
enzyme, 3B
RNASEH2A 3.0 4.1 Ribonuclease H2, large subunit
Immune response
PTX3 NC 3.6 Pentraxin-related gene,
induced by IL-1 beta
MICB NC 2.6 MHC class I polypeptide-related
sequence B
Downregulated genes
ADAMTS5 −2.0 −2.3 A disintegrin and metalloproteinase-
thrombospondin motif, 5
COL3A1 −1.8 −3.1 Collagen, type III, alpha 1
COL1A2 −1.9 −2.2 Collagen, type I, alpha 2
NC: no change in gene expression.
Table 2
Comparison of Quantitative RT-PCR and Microarray Results.
Gene
symbol
qRT-PCR
change,a 48 hpi
Microarray
change, 48 hpi
qRT-PCR
change, 72 hpi
Microarray
change, 72 hpi
CDC2 4.6 8.3 12.9 13.6
CDC6 8.0 9.0 20.0 16.2
CCNE2 12.3 14.1 31.2 24.3
COL3A1 -1.4 -1.8 -3.1 -3.1
COL1A2 -1.9 -1.9 -4.0 -2.2
B2M 1.3 1.0 -1.3 1.0
a Expressed as fold difference between BKV-infected and mock-infected cells, with
relative levels of CDC2, CDC6, cyclin E2, collagen type I, alpha 2, and collagen type III,
alpha 1 transcripts normalized to the levels of β-2-microglobulin transcripts in each
sample. hpi, hours post-infection.
Fig. 1. Increased expression of CDC2 and CDC6 after BKV infection. HPTE cells were
infected with BKV at an MOI of 5 IU/cell and total cellular protein was extracted at 48
and 72 hpi. 25 μg of protein lysate was analyzed for the expression of CDC2, CDC6, or
GAPDH by Western blotting.
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tubule epithelial cells (Daha and van Kooten, 2000; Frank et al., 1993;
Gerritsma et al., 1998), we observed no reproducible differences of
more than two-fold for detectable genes (data not shown).Quantitative RT-PCR conﬁrmation of microarray results
To conﬁrm the results of the microarray analysis, we performed
quantitative RT-PCR on selected genes that were signiﬁcantly changed
during BKV infection. cDNA was synthesized from the RNA samples
isolated at 48 and 72 hpi and the relative levels of CDC2, CDC6, CCNE2,
COL1A2, and COL3A1 transcripts in BKV-infected or mock-infected
samples were determined, normalizing to levels of β2-microglobulin
transcripts, which remained unchanged during infection. Table 2
shows a comparison of the results from the quantitative RT-PCR assay
with those of the microarray analysis. The quantitative RT-PCR assay
conﬁrmed that the steady-state levels of CDC2, CDC6, and CCNE2
transcripts were upregulated in BKV-infected HPTE cells at both 48
and 72 hpi, while the levels of COL1A2 and COL3A1 were down-
regulated at both time points. In addition, the relative change in
transcript levels at each time point was very similar between the two
assays, further supporting the results of the microarray analysis. The
changes in levels of β-2-microglobulin transcripts were determined
by averaging the fold difference between BKV-infected and mock-
infected samples in all ﬁve assays at each time point.
Conﬁrmation of microarray results at the level of protein expression
To determine whether the levels of CDC2 and CDC6 protein were
changed in a manner consistent with the microarray and quantitative
RT-PCR results, we performed Western blot analysis. HPTE cells were
infected with puriﬁed BKV at an MOI of 5 IU/cell and total cellular
protein was extracted at 48 and 72 hpi, and we examined the
expression of CDC2, CDC6, or GAPDH as a loading control (Fig. 1). At
both 48 and 72 hpi, we observed increased expression of CDC2 and
CDC6 in the BKV-infected sample as compared to the mock-infected
sample, verifying the results of the RNA analyses.
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In this study, we were interested in determining how BKV affects
the cellular environment in the context of a lytic infection. We
expected that TAg interactions with pRB and p53, both of which
control the transcription of various target genes, would change the
transcriptional proﬁle of the cell. In addition, most pathogens trigger
an intracellular innate immune response by binding to pattern
recognition receptors in the cell (Mogensen, 2009). Our studies
show that infection of primary kidney epithelial cells with BKV
upregulated the expression of a large number of cellular genes. Many
of these genes can be categorized as cell cycle and proliferation factors
and, more speciﬁcally, targets of p53 and E2F transcription factors.
Genes involved in apoptosis, signal transduction, transcriptional
regulation, DNA damage repair, protein ubiquitination and folding,
RNA processing, and cellular trafﬁcking and structure were also
upregulated during infection. In Supplemental Tables 1 and 2, we have
provided the comprehensive results of the microarray analysis
organized into these functional categories. It should be noted that
some genes could be placed in more than one category. Interestingly,
while the expression of many genes was activated, the transcript
levels of only four genes decreased during BKV infection. To conﬁrm
the results of the microarray analysis, the steady-state RNA levels of
CDC2, CDC6, CCNE2, COL1A2, and COL3A1 were analyzed by
quantitative RT-PCR. Furthermore, the changes in levels of protein
expression of CDC2 and CDC6 were conﬁrmed by Western blot
analysis. The results of this study provide information about how BKV
manipulates the host cell environment during a lytic infection.
We anticipated that the expression of genes that regulate cell cycle
and proliferation would be elevated in the context of BKV lytic
infection, based on our knowledge of the BKV genome and the
activities of TAg. Like other DNA viruses, BKV does not encode
enzymes for DNA synthesis and therefore must rely on the host cell
replication machinery during productive infection. The interaction of
TAg with pRB results in the activation of the E2F transcription factor
family, which regulates the expression of many genes involved in cell
cycle progression and DNA replication. The subsequent change in the
transcriptional proﬁle of the cell provides an optimal environment for
viral replication. Others have reported the upregulation of a similar
set of genes in the presence of JCV and SV40. Two independent
microarray studies of JCV infection have shown elevated levels of cell
cycle-associated genes that our results indicate are also affected in the
presence of BKV, including members of the cyclin and CDC families
(Radhakrishnan et al., 2003; Verma et al., 2006). Studies examining
gene expression in SV40 TAg transformed cells or transgenic mouse
models by microarray analysis have made similar observations (Guo
et al., 2006; Larsson et al., 2004).
Another study described the microarray analysis of cellular
transcriptional changes during BKV infection of HUV-EC-C cells, a
spontaneously immortalized cell line derived from human umbilical
vein endothelial cells (Grinde et al., 2007). There are similarities
between the results of that study and ours, including the upregulation
of genes involved in cell cycle regulation. However, in the BKV-
infected HUV-EC-C cells, a large number of genes were also down-
regulated: 249 genes at 24 hpi and 104 genes at 40 hpi. The authors
also noted that transcripts involved in viral defense were among those
downregulated, suggesting that BKV was actively diminishing the
cellular antiviral response. While this study is similar to ours in nature
and intent, we believe that the primary kidney proximal tubule
epithelial cells we used are more relevant for the examination of BKV
lytic infection. The differences in cell type (epithelial versus
endothelial) and the state of the cell (primary versus immortalized),
and the subsequent differences in the stage of infection examined
could account for the differences between the two analyses.
It has previously been shown that BKV TAg interaction with p53
can result in inhibition of p53-mediated apoptosis (Harris et al.,1998). In our study, increased levels of anti-apoptotic transcripts, such
as BIRC5 (survivin), GTSE1, and BCL2L12, were observed at both 48
and 72 hpi of kidney epithelial cells. The upregulation of these anti-
apoptotic genes may prolong the life of the host cell during lytic
infection and maximize the production of viral progeny. Simulta-
neously, however, there were increased levels of pro-apoptotic
transcripts, such as CASP8AP2, APAF1, and SIVA, in BKV-infected
cells in our studies. Such an opposing effect may indicate a cellular
response to the deregulation of the cell cycle resulting from the
interaction of TAg and pRB family members.
It is interesting to note the elevated expression of genes involved
in chromatin remodeling, structure, and assembly during infection.
The BKV genome is associated with cellular histones H2A, H2B, H3,
and H4 to form a cellular chromatin-like structure known as the
minichromosome (Meneguzzi et al., 1978). Therefore, the induction
of chromatin remodeling enzymes may be an important regulatory
mechanism for viral DNA replication and transcription, as well as for
cellular gene expression. In particular, levels of DNA methyltransfer-
ase 1 (DNMT1), which is mainly associated with transcriptional
repression, were increased at 48 and 72 hpi in themicroarray analysis,
which correlates with our previous results demonstrating increased
steady-state levels of DNMT1 in infected cells (McCabe et al., 2006).
The activation of genes involved in chromatin remodeling and
modiﬁcation could contribute to BKV-associated disease in several
ways. For example, expression of such proteins could result in the
repression of cytokine production, allowing BKV to evade the immune
system. This effect may be especially important in the context of
infected kidney proximal tubule cells, which function in immune
activation (Daha and van Kooten, 2000; Frank et al., 1993).
Modiﬁcation of viral chromatin may control the level of viral DNA
replication or the state of infection under different conditions.
Furthermore, in a nonpermissive cell, hypermethylation of tumor
suppressor genes may promote BKV transformation (Herman, 1999).
Genes involved in DNA damage repair were also highly upregu-
lated during infection, including multiple members of the RAD family
of proteins (RAD51, RAD51AP1, RAD54B, RAD18), BRCA1, BRCA1-
associated proteins (BRIP1, BARD1), and the histone variant H2AX.
The elevated expression of these proteins may indicate the cellular
response to TAg-mediated disruption of DNA repair mechanisms,
which are documented for SV40 and JCV (Digweed et al., 2002; Reiss
et al., 2006). It has recently been suggested that SV40 uses the DNA
damage repair pathway to effect its own replication (Zhao et al.,
2008), and BKV may use the same strategy. Interestingly, SV40 TAg
binds the spindle checkpoint protein, Bub1, leading to a DNA damage
response (Hein et al., 2009), and BKV activates expression of both the
BUB1 gene and its homolog, BUB1B, to high levels.
Remarkably, only four genes were signiﬁcantly downregulated
over the course of BKV infection of proximal tubule cells. The
metalloprotease ADAMTS5, which has a putative role in cartilage
degradation in osteoarthritis, was the only gene downregulated by
more than two-fold at both 48 and 72 hpi. Previous studies
characterizing ADAMTS5 suggest that regulation typically occurs at
the post-translational level (Vankemmelbeke et al., 2001; Yamanishi
et al., 2002). Our results, however, suggest instead that BKV regulates
ADAMTS5 at the level of transcription, though it is unclear what role
this protein plays during infection. Two collagen transcripts, COL1A2
and COL3A1, were also expressed at lower levels in the presence of
BKV. In agreement with our ﬁndings, a decrease in collagen
expression has previously been observed in ﬁbroblasts transformed
with SV40 (Bankowski et al., 1978; Parker and Gevers, 1984; Parker et
al., 1982). Furthermore, transcript levels of GSTA4, a glutathione S-
transferase that detoxiﬁes lipid peroxidation products, were de-
creased during both BKV infection of HPTE cells and SV40 infection of
human ﬁbroblasts and liver cells (Bravard et al., 1993; Sompayrac,
1997). The similarities between our results and those of previous
reports in which microarray analysis was not employed support our
Table 3
Primers and probes used for quantitative RT-PCR (Taqman assay).
Target
gene
Primers/
probes
Sequence (5' to 3') Amplicon
size (bp)
CDC2 Forward TGACATTTGGAGTATAGGCACCATA 100
Reverse TCTGAAAATCCTGAAGAGTTGATCA
Probe TTGCTGAACTAGCAACTAAGAAACCACTTTTCCAT
CDC6 Forward CCATGATTGTGTTGGTATTG 110
Reverse GCACCAAGTGAGAATTGCTT
Probe CAAATAGCGTGTACAATACATCCTGGCCTT
CCNE2 Forward TGTTTGTGAAACTGTTAAGGTCCTTT 107
Reverse CCTTAAGAAAATAGAAGTTTAGGTCAAGTGT
Probe AAGCTTTATCACTTTGACACTGTCCTTATCTCACAAT
COL1A2 Forward GCAGATTATTTGCCCAAATCT 85
Reverse CTGTGGAACCATGGAAGAAG
Probe CAGATTCAGCATTTGTTCTTTGCCAGTC
COL3A1 Forward TAGCTACGGCAATCCTGAAC 145
Reverse TACATTTCCACTGGCCTGAT
Probe CTTCCCAGAACATCACATATCACTGCAA
B2M Forward TGGAGGCTATCCAGCGTACT 115
Reverse TCAATGTCGGATGGATGAAA
Probe TCCAGCAGAGAATGGAAAGTCAAATTTCCT
77J.R. Abend et al. / Virology 397 (2010) 73–79overall ﬁndings, including the paucity of downregulated genes.
Studies involving cellular changes induced by expression of human
cytomegalovirus IE86 in human ﬁbroblasts show the same pattern:
upregulation of hundreds of genes, mainly those involved in cell cycle
and proliferation, and downregulation of very few transcripts (Song
and Stinski, 2002). It is possible that at later stages of infection, BKV
may downregulate additional transcripts, perhaps through interac-
tions withmethyltransferases and other chromatin remodeling genes.
During BKV infection of the human host, the virus establishes a
persistent infection primarily in kidney epithelial cells until the host
environment changes in immunosuppressed patients to favor lytic
infection. Considering that kidney proximal tubule cells play a role in
immune monitoring and activation, we anticipated that genes
involved in regulation of the immune response would be affected by
BKV infection. Our analysis, however, revealed that BKV has no overall
effect on genes in this category. Only two pro-inﬂammatory genes
were signiﬁcantly upregulated during infection: pentraxin 3 (PTX3), a
cytokine-inducible protein implicated in innate immunity and
inﬂammation (Bottazzi et al., 2006), and MICB, an MHC class I-related
molecule that regulates the innate immune response by interacting
with the NKG2D receptor on NK and cytotoxic T cells (Collins, 2004).
The cytokine-targeted PCR array analysis performed at 4 hpi and the
RPA analyses conﬁrmed that BKV does not appear to induce a pro-
inﬂammatory response. Using ELISA, we also observed that BKV
infection of HPTE cells had no effect on levels of MCP-1, IL-6, and IL-8,
cytokines known to be expressed by proximal tubule cells (data not
shown; Frank et al., 1993; Gerritsma et al., 1998).
There are at least three possible explanations for the lack of
regulation of genes involved in cytokine expression and immune
activation during infection. First, BKV may have developed mechan-
isms that prevent immune activation during infection, which could
include both modulation of cellular gene expression by viral proteins
and, especially at very early times post-infection, an entry pathway
that avoids the cellular innate immune surveillance mechanisms
(Mogensen, 2009). We have recently demonstrated that BKV trafﬁcs
through an endocytic compartment to the endoplasmic reticulum,
where disassembly of the virus begins (Jiang et al., 2009b). It is
possible that this route through the cytoplasm does not bring any viral
components in contact with innate immune receptors. Second, BKV
may actively inhibit pro-inﬂammatory signaling in the cell. Third, it is
possible that HPTE cells are not able to elicit an antiviral immune
response in the given experimental context.
In this study, we have characterized the effect of BKV on gene
expression in primary human kidney cells at the early and late stages
of infection.We observed the upregulation of a large number of genes,
particularly those involved in cell cycle and proliferation, and
speculate that this is a result of the stimulatory nature of BKV early
proteins and subsequent activation of E2F. Very few transcripts were
downregulated during infection and there was no activation of a pro-
inﬂammatory response in the cells, suggesting that BKV may evade
the immune response by avoiding the regulation of certain tran-
scripts. This study provides an important collection of data detailing
the host-pathogen interaction between BKV and kidney epithelial
cells, the major site of lytic replication in patients with PVN.
Materials and methods
Microarray analysis
Primary human proximal tubule epithelial (HPTE) cells were
grown as previously described (Low et al., 2004). 1.0×106 HPTE cells
plated in T-25 tissue culture ﬂasks were infected at 70% conﬂuence
using puriﬁed BKV strain TU at an MOI of 5 infectious units per cell
(IU/cell). Cells were incubated with the virus in 1 ml of growth media
at 37 °C for 1 h, with rocking every 15 min. Inoculating medium was
removed and the cells were washed three times with 1ml PBS. 3 ml ofgrowth media were then added and the cells were incubated at 37 °C
with 5% CO2 in a humidiﬁed incubator. Infections were performed in
duplicate or triplicate and allowed to progress for 24, 48, or 72 h. RNA
was isolated using the Qiagen RNeasy Mini Kit according to the
manufacturer’s instructions. RNA samples were quantiﬁed using an
Eppendorf spectrophotometer by measuring the absorbance at
260 nm. RNA purity and quality were determined using Agilent RNA
6000 Nano Eukaryote Total RNA LabChips analyzed on an Agilent
2100 BioAnalyzer. Biotin-labeled cDNA was produced from 10 μg of
total cellular RNA and hybridized to the Affymetrix GeneChip Human
Genome U133 Plus 2.0 Array according to the manufacturer’s
suggested protocol (http://gg.bu.edu/microarray/expression_man-
ual.pdf). Sequence clusters were obtained from the Unigene database
(Build 133, April 20, 2001). These procedures were performed at the
University of Michigan Comprehensive Cancer Center DNA Micro-
array Core Facility. The arrays were scanned using an Affymetrix
GeneChip Scanner to obtain .cel ﬁles. The ﬁles were then analyzed
using dChip software (www.dchip.org) and expression proﬁles for
each transcript were generated using a robust microarray average.
The expression values were analyzed with a principal components
analysis to determine if the replicated samples grouped together.
Once appropriate grouping was determined, the data were ﬁltered to
remove from the analysis any genes with expression levels less than
26 relative intensity units, those genes expressed at levels similar to
background. The remaining genes were analyzed using a T test of
variance, and a two-fold cutoff was used to deﬁne signiﬁcant changes.
Targeted PCR array analysis
HPTE cells were grown to 70% conﬂuence in 12 well plates. To
synchronize the infection due to the short duration of the infection,
cells were prechilled at 4 °C for 15 min and then incubated for 1 h at
4 °C with puriﬁed BKV TU at an MOI of 5 IU/cell. Inoculating medium
was removed and cells were washed once with cold media. 1 ml of
37 °C growthmediawas then added to initiate viral entry and the cells
were incubated at 37 °C with 5% CO2 in a humidiﬁed incubator for 4 h,
at which point total cell RNA was harvested as described above. RNA
integrity was conﬁrmed by electrophoresis on an agarose gel and 1 μg
of RNA was converted to cDNA using the RT² First Strand Kit
(SABiosciences, cat #C-03), according to manufacturer's instructions.
Diluted cDNA was added to the RT² SYBR Green/Fluorescein qPCR
Master Mix (SABiosciences, cat #PA-011). Human Common Cytokines
RT² Proﬁler PCR Arrays (SABiosciences, cat #PAHS-021A) were loaded
with 25 μl/well of cDNA-master mix and the following PCR program
78 J.R. Abend et al. / Virology 397 (2010) 73–79was used for ampliﬁcation: 10 min at 95 °C; 40 cycles of denaturation
at 95 °C for 15 s and annealing and extension at 60 °C for 1 min,
followed by standardmelt curve analysis. Results were analyzed using
RT² Proﬁler PCR Array Data Analysis Template v3.0, using levels of β-
actin (ACTB) and gylceraldehyde-3-phosphate dehydrogenase
(GAPDH) to normalize mock and infected sample pairs. PCR arrays
were performed on mock- and BKV-infected total cell RNA from two
independent experiments; the results are shown in separate columns
in Supplemental Table 3.
Quantitative RT-PCR
RNA samples were treated with DNase I (Promega) to reduce
contaminating DNA, and RNA integrity was conﬁrmed by electropho-
resis on an agarose gel. To generate cDNA, a reverse transcription
reaction was performed using 500 ng RNA as template and the iScript
cDNA Synthesis Kit (Bio-Rad), according to manufacturer's instruc-
tions. Primers and probes were designed to amplify 85- to 145-base
pair fragments of CDC2, CDC6, cyclin E2 (CCNE2), collagen type I,
alpha 2 (COL1A2), collagen type III, alpha 1 (COL3A1), and β-2-
microglobulin (B2M) using Primer3 software (Table 3; Rozen and
Skaletsky, 2000). Primers were synthesized by Invitrogen. Oligonu-
cleotide probes, synthesized by Integrated DNA Technologies, Inc.,
were tagged with 6-ﬂuorescein (FAM) as the reporter dye at the 5'
end and TAMRA-Sp as the quencher dye at the 3' end. Quantitative
PCR reactions were performed in a total volume of 25 μl using TaqMan
Universal PCR 2× master mix (Applied Biosystems), 200 nM of probe,
either 1200 nM (for ampliﬁcation of the gene of interest) or 500 nM
(for ampliﬁcation of B2M) of each primer, and 2.5 μl of the cDNA
template. Ampliﬁcation was performed in 96-well PCR plates using
the iCycler iQ5 Real Time Detection System (Bio-Rad). The following
PCR program was used for ampliﬁcation: 2 min at 50 °C; 10 min at
95 °C; 50 cycles of denaturation at 95 °C for 15 s and annealing and
extension at 58 °C (or 60 °C for COL3A1) for 1 min. Results are
presented as fold change in target gene transcript levels relative to
levels inmock-infected samples, normalized to B2Musing the 2−ΔΔC(t)
method (Livak and Schmittgen, 2001).
Western blotting
Total cell protein was extracted using E1A lysis buffer (Harlow et
al., 1986) containing 0.05 M NaF and Complete EDTA-free Proteinase
Inhibitors (Roche). Protein concentration was determined using the
Bio-Rad protein assay, and 25 μg of protein were electrophoresed on
an 8% SDS/polyacrylamide gel. Proteins were transferred to nitrocel-
lulose membrane as previously described (Low et al., 2006).
Membraneswere probed overnight at 4 °C with the following primary
antibodies in PBS-TM (PBS containing 0.1% Tween 20 and 5% non-fat
dry milk): anti-Cdk1 (Sigma, catalog #C4973) to detect CDC2, DCS-
180 (Sigma, catalog #C0224) to detect CDC6, and 6C5 (Abcam, catalog
#Ab8245) to detect GAPDH. Primary antibodies were detected using
horseradish peroxidase-conjugated secondary antibodies (Amer-
sham) in PBS-TM and observed using the ECL Plus Western blotting
detection system (Amersham).
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